PCI strategies in patients with acute myocardial infarction and cardiogenic shock

New England Journal of Medicine

Volumn 377, Issue 25, 2017, Pages 2419-2432

  Thiele, H ^a   Akin, I ^b   Sandri, M ^a   Fuernau, G ^c,d   De Waha, S ^c,d   Meyer Saraei, R ^c,d   Nordbeck, P ^f   Geisler, T ^g   Landmesser, U ^d,e   Skurk, C ^d,e   Fach, A ^h   Lapp, H ⁱ   Piek, J J ⁿ   Noc, M ^o   Goslar, T ^o   Felix, S B ^d,j   Maier, L S ^k   Stepinska, J ^p   Oldroyd, K ^q   Serpytis, P ^r   Montalescot, G ^s   Barthelemy, O ^s   Huber, K ^u   Windecker, S ^v   Savonitto, S ^w   Torremante, P ^t   Vrints, C ^x   Schneider, S ^l   Desch, S ^a,d   Zeymer, U ^l,m   more..

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c University Heart Center Lübeck   (Germany)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h Klinikum Links der Weser   (Germany)

ⁱ HELIOS KLINIKUM ERFURT   (Germany)

^j UNIVERSITY OF GREIFSWALD   (Germany)

^k Universitares Herzzentrum Regensburg   (Germany)

^l Institut fur Herzinfarktforschung   (Germany)

^m KLINIKUM LUDWIGSHAFEN   (Germany)

ⁿ ACADEMIC MEDICAL CENTER   (Netherlands)

^o UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^p INSTITUTE OF CARDIOLOGY   (Poland)

^q GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^r VILNIUS UNIVERSITY   (Lithuania)

^s SORBONNE UNIVERSITÉ   (France)

^t Applied Research ISC Paris   (France)

^u SIGMUND FREUD UNIVERSITY   (Austria)

^v UNIVERSITY OF BERN   (Switzerland)

^w A MANZONI HOSPITAL   (Italy)

^x ANTWERP UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIVALIRUDIN; CANGRELOR; CATECHOLAMINE; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; STATIN (PROTEIN); TICAGRELOR; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DISEASE SEVERITY; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; MULTICENTER STUDY; OPEN STUDY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; CORONARY ARTERY DISEASE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROCEDURES; RISK; TIME TO TREATMENT;

AGED; CORONARY ARTERY DISEASE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY; RISK; SHOCK, CARDIOGENIC; TIME-TO-TREATMENT;

EID: 85039766376     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1710261     Document Type: Article

References (23)

1. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295: 2511-5.
2. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625-34.
3. Thiele H, Ohman EM, Desch S, Eitel I, de Waha S. Management of cardiogenic shock. Eur Heart J 2015; 36: 1223-30.
4. Thiele H, Desch S, Piek JJ, et al. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: design and rationale of CULPRIT-SHOCK trial. Am Heart J 2016; 172: 160-9.
5. Sanborn TA, Sleeper LA, Webb JG, et al. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol 2003; 42: 1373-9.
6. Webb JG, Lowe AM, Sanborn TA, et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 2003; 42: 1380-6.
7. Wong SC, Sanborn T, Sleeper LA, et al. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000; 36: Suppl A: 1077-83.
8. Smits PC, Abdel-Wahab M, Neumann F-J, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med 2017; 376: 1234-44.
9. Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013; 369: 1115-23.
10. Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 2015; 65: 963-72.
11. Engstrom T, Kelbak H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet 2015; 386: 665-71.
12. de Waha S, Jobs A, Eitel I, et al. Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: a systematic review and metaanalysis. Eur Heart J Acute Cardiovasc Care 2017 July 1 (Epub ahead of print).
13. Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2017 August 26 (Epub ahead of print) (https:/ / doi. org/ 10. 1093/ eurheartj/ ehx393).
14. Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol 2016; 67: 1235-50.
15. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/ STS 2016 appropriate use criteria for coronary revascularization in patients with acute coronary syndromes: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2017; 69: 570-91.
16. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-47.
17. Alexander JH, Reynolds HR, Stebbins AL, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 2007; 297: 1657-66.
18. Thiele H, Zeymer U, Neumann F-J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of the randomised, open-label trial. Lancet 2013; 382: 1638-45.
19. Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-96.
20. Sardella G, Lucisano L, Garbo R, et al. Single-staged compared with multistaged PCI in multivessel NSTEMI patients: the SMILE Trial. J Am Coll Cardiol 2016; 67: 264-72.
21. van der Schaaf RJ, Claessen BE, Vis MM, et al. Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock. Am J Cardiol 2010; 105: 955-9.
22. Hoebers LP, Vis MM, Claessen BE, et al. The impact of multivessel disease with and without a co-existing chronic total occlusion on short-and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock. Eur J Heart Fail 2013; 15: 425-32.
23. Henriques JPS, Hoebers LP, Ramunddal T, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE Trial. J Am Coll Cardiol 2016; 68: 1622-32.